Anti-infection of Low-does IL-2 in SLE
NCT02932137
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
Interleukin-2
Sponsor
Peking University People's Hospital